Trade Gilead ^GILD

Erste Group Bank Estimates Gilead Sciences FY2027 Earnings

Why Morgan Stanley likes Gilead's HIV prevention play

Gilead Sciences (NASDAQ:GILD) Rating Increased to Buy at Wall Street Zen

Gilead Sciences (NASDAQ:GILD) Upgraded to Buy at Wall Street Zen

Insider Selling: Gilead Sciences (NASDAQ:GILD) CFO Sells $435,870.00 in Stock - Daily Political

Gilead Strengthens HIV Growth Platform with Expanded Latin America Access

Top Medical Stocks To Watch Today - September 18th - Daily Political

Nykredit A S Invests $140.59 Million in Gilead Sciences, Inc. $GILD

Top Medical Stocks To Keep An Eye On - September 17th - Stock Observer

Dr Reddy's inks licensing deal with Gilead for once-yearly HIV lenacapavir

Biotech Stocks To Keep An Eye On - September 17th - Stock Observer

Dr Reddy's Labs Secures License for Gilead's Revolutionary Once-Yearly HIV Prevention Drug, ETPharma

Dr. Reddy's expands Gilead pact for HIV prevention drug

Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock

Insider Selling: Gilead Sciences (NASDAQ:GILD) Insider Sells $432,660.00 in Stock

Johanna Mercier Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - Stock Observer

Gilead Partners with PAHO to Expand Access to HIV Prevention Drug in Latin America and Caribbean, ETPharma

Medical Stocks To Consider - September 15th - Zolmax

Gilead Sciences Sees Yeztugo Powering HIV Growth as Oncology Pipeline Advances - Stock Observer

Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean

Gilead Sciences (GILD) Gains As Market Dips: What You Should Know

Gilead Sciences Target of Unusually High Options Trading (NASDAQ:GILD) - Daily Political

Gilead Sciences, Inc. (GILD) To Go Ex-Dividend on September 15th

Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC

The Manufacturers Life Insurance Company Sells 148,344 Shares of Gilead Sciences, Inc. $GILD

Bullseye Investment Management LLC Takes Position in Gilead Sciences, Inc. $GILD

Gilead Wins Appeals Court Ruling Blocking Imported HIV Drug Sales

16,506 Shares in Gilead Sciences, Inc. $GILD Bought by Bullseye Investment Management LLC - Stock Observer

Best Medical Stocks To Research - September 11th - Daily Political

Baird Financial Group Inc. Grows Holdings in Gilead Sciences, Inc. $GILD

RBC Capital Keeps Their Hold Rating on Gilead Sciences (GILD)

Gilead Sciences Sees Sunlenca Launch Fueling Long-Term HIV Growth

Tidal Investments LLC Raises Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Acquired by National Pension Service

112,886 Shares in Gilead Sciences, Inc. $GILD Purchased by Engineers Gate Manager LP - Zolmax

Gilead Sciences Eyes HIV, Oncology Catalysts as Pipeline Enters Execution Mode - Stock Observer

Triple Negative Breast Cancer Market to Reach Significant Growth by 2036, Driven by Advancements in Immunotherapy, Targeted Therapies, and Next-generation Treatment Approaches | DelveInsight | ABNewswire

Promising Medical Stocks To Research - September 9th - Markets Daily

Sofinnova Investments Announces the Appointment of Dr. Merdad Parsey as Executive Partner | Morningstar

NewEdge Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program With Gilead | Morningstar

Arizona State Retirement System Raises Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences, Inc. $GILD Shares Purchased by Groupe la Francaise

California State Teachers Retirement System Has $30.47 Billion Stake in Gilead Sciences, Inc. $GILD

Bixlenvo Gives Gilead a New HIV Growth Path. How Large is the Market?

Promising Biotech Stocks To Consider - September 7th - Zolmax

Gilead Sciences, Inc. $GILD Holdings Raised by HighTower Advisors LLC

VIRGINIA RETIREMENT SYSTEMS ET Al Takes $130.42 Million Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (NASDAQ:GILD) Stock Rating Lowered by Wall Street Zen - Daily Political

Medical Stocks To Follow Now - September 6th

Saudi Central Bank Acquires 41,091 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Downgraded to Hold Rating by Wall Street Zen - Zolmax

Saudi Central Bank Grows Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?

Gilead Sciences (NASDAQ:GILD) Lowered to Hold Rating by Wall Street Zen

Will New HIV and Oncology Approvals Redefine Gilead Sciences' (GILD) Treatment Platform Narrative?

Kymera Therapeutics (KYMR) Up 10.2% Since Last Earnings Report: Can It Continue?

Top Medical Stocks To Consider - September 4th - Daily Political

NEOS Investment Management LLC Has $120.08 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer

Why Is Gilead (GILD) Up 13.6% Since Last Earnings Report?

Is Gilead Sciences Stock Outperforming the S&P 500?

Nykredit A S Makes New $177.13 Million Investment in Gilead Sciences, Inc. $GILD

iSAM Funds UK Ltd Buys New Stake in Gilead Sciences, Inc. $GILD

B. Metzler seel. Sohn & Co. AG Boosts Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences Q1 EPS Estimate Raised by Zacks Research - Daily Political

iSAM Funds UK Ltd Makes New $2.02 Million Investment in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock

ITOC, PTHL Deadline Alert: Levi & Korsinsky Reminds iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) (ITOC, PTHL) Investors of Securities Class Action Deadline on September 29, 2026 | Morningstar

Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?

Gilead Sciences (NASDAQ:GILD) Raised to "Strong-Buy" at Zacks Research

Gilead takes a 'different' approach to reaching the Black community with new HIV campaign

Gilead Sciences (NASDAQ:GILD) Upgraded by Zacks Research to "Strong-Buy" Rating - Stock Observer

Can Bixlenvo Unlock New Growth for Gilead's HIV Business?

Wall Street Analysts See Gilead (GILD) as a Buy: Should You Invest?

Erste Group Bank Comments on Gilead Sciences FY2026 Earnings

Railway Pension Investments Ltd Cuts Position in Gilead Sciences, Inc. $GILD - Zolmax

Railway Pension Investments Ltd Sells 7,769 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Analysts

FY2026 EPS Estimate for Gilead Sciences Increased by Analyst - Stock Observer

Best Biotech Stocks Worth Watching - August 31st - Daily Political

Headlands Technologies LLC Buys Shares of 49,478 Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Quantitative Investment Management LLC - Stock Observer

Promising Medical Stocks To Consider - August 30th

Promising Pharmaceutical Stocks Worth Watching - August 30th - Daily Political

Hennessy Advisors Inc. Raises Stake in Gilead Sciences, Inc. $GILD

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Position in Gilead Sciences, Inc. $GILD

Van ECK Associates Corp Sells 488,138 Shares of Gilead Sciences, Inc. $GILD

Flputnam Investment Management Co. Sells 67,582 Shares of Gilead Sciences, Inc. $GILD

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Avalanche Price Prediction 2026–2030: Can Institutional Tokenization Push AVAX Back Above $10?

Week Ahead: PBoC and SNB rate decisions

Gold Price Forecast 2026, 2027 and 2030: Can Gold Hold $4,200 After the Fed’s First Rate Hike Since 2023?

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

x402 Ecosystem Competition Analysis: Launchpads, Facilitators, and Providers

Intel Stock Surges 12% as AI Chip Rally and SK Hynix Ohio Talks Lift Sentiment

Gold Price Today Rises Above $4,350 as Lower Oil Prices Ease Rate Concerns

Bitcoin Price Today Hits Eight-Month High Above $86,000 as ETF Inflows and Short Squeeze Fuel Rally

AMD Stock Soars 10% and Joins the $1 Trillion Club as AI Chip Rally Returns

ASML Stock Rises 3% as AI Chip Rally and Samsung High-NA EUV Plans Lift Sentiment

Meta’s Muse Ignites a “Quiet” Nasdaq Surge as Micron Earnings Become the Next AI Test

Critical Metals Stock Soars 38% as Trump’s Greenland Deal Ignites Rare-Earth Shares

SpaceX Nasdaq-100 Weight More Than Doubles, Setting Up Billions in Passive Buying